An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone asked online: they’re 21, checked their IGF-1 blood level (a lab number tied to growth-hormone activity), and it came back at 360 ng/mL, which a clinician told them is on the high side for their age. They were considering taking growth-hormone–releasing peptides (GHRH mimics) like CJC-1295 + ipamorelin or tesamorelin, and want to know what would realistically happen if they still used them. IGF-1 stands for insulin-like growth factor 1. It’s a protein made mostly in the liver when growth hormone (GH) is active. Doctors often measure it as a rough readout of how much GH signaling your body has had over the past few days or weeks. GHRH peptides are compounds that try to raise your own GH release from the pituitary gland (the small gland at the base of the brain). Tesamorelin is a lab-made peptide approved for a specific medical use (reducing belly fat in people with HIV), while combinations like CJC-1295 plus ipamorelin are sold in the supplement/experimental market to push GH pulses. The idea is they boost GH, which then raises IGF-1. What the evidence and basic physiology suggest is straightforward: if your IGF-1 is already relatively high for your age, taking GHRH-type peptides would likely push it higher. Most of the human data we have shows these peptides transiently increase GH and raise IGF-1 over time. How much it would change for one person depends on dose, frequency, individual sensitivity, and baseline levels. But higher IGF-1 is not benign: it can cause side effects like joint pain, fluid retention, numbness or tingling, and can worsen glucose control (raising blood sugar). For someone whose IGF-1 is already elevated, the additional push could magnify those risks and would not be predictable from a single number. This matters because people chase GH-related benefits—more muscle, less fat, better recovery—but the balance of benefit versus risk changes with starting levels. A 21-year-old whose IGF-1 is already high may not gain much extra benefit and is more likely to experience downsides. Also, lab ranges vary by lab and by how they define “normal” for age and sex, so a single test needs context. Anyone thinking about using these peptides should pause and ask why their IGF-1 is high in the first place; sometimes it’s natural variation, sometimes it reflects a lab or timing issue, and rarely it points to a medical condition that requires evaluation. Key cautions: many GHRH peptides sold online are not regulated, and quality/dosing can be unreliable. Tesamorelin is prescription-only for a specific condition and was studied and approved in that narrow group—not for general anti-aging or bodybuilding. Raising GH/IGF-1 can cause water retention, joint or nerve symptoms, and impaired blood sugar control; long-term effects on cancer risk are still a concern in medical discussions. If your IGF-1 is outside expected ranges, the safest step is to discuss with a doctor or an endocrinologist before trying to boost growth hormone further. They can repeat tests, check other hormones, and advise whether any treatment is justified. Bottom line: with an already-high IGF-1, using GHRH peptides would probably raise it more and increase the chance of side effects, so it’s wise to avoid them until a clinician evaluates why your level is elevated.
Source: r/Peptides